Literature DB >> 7539824

Detection of T cells responsive to a vascular growth factor in rheumatoid arthritis.

V M Byrd1, X M Zhao, G G Miller, J W Thomas.   

Abstract

The primary lesion in rheumatoid arthritis (RA) is a destructive synovitis characterized by proliferation of endothelial cells, fibroblasts, and vascular smooth muscle cells, and with perivascular lymphocyte aggregates. A nonhematopoietic growth factor, acidic fibroblast growth factor (aFGF), may induce many of the biological features found in rheumatoid synovium, including T cell activation. To determine if aFGF-responsive T cells are increased in RA, we developed an assay to measure the frequency of peripheral blood T cells that are costimulated by aFGF. The data indicate that the frequency of aFGF-responsive T cells is increased in RA and may change with disease activity and treatment.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7539824     DOI: 10.1007/bf02918274

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  29 in total

Review 1.  Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy.

Authors:  R H Schwartz
Journal:  Cell       Date:  1992-12-24       Impact factor: 41.582

2.  Isolation of an additional member of the fibroblast growth factor receptor family, FGFR-3.

Authors:  K Keegan; D E Johnson; L T Williams; M J Hayman
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

Review 3.  Angiogenic factors.

Authors:  J Folkman; M Klagsbrun
Journal:  Science       Date:  1987-01-23       Impact factor: 47.728

Review 4.  The heparin-binding (fibroblast) growth factor family of proteins.

Authors:  W H Burgess; T Maciag
Journal:  Annu Rev Biochem       Date:  1989       Impact factor: 23.643

Review 5.  Fibroblast growth factor: structural and biological properties.

Authors:  D Gospodarowicz; G Neufeld; L Schweigerer
Journal:  J Cell Physiol Suppl       Date:  1987

6.  Alternative splicing generates two forms of mRNA coding for human heparin-binding growth factor 1.

Authors:  I M Chiu; W P Wang; K Lehtoma
Journal:  Oncogene       Date:  1990-05       Impact factor: 9.867

7.  Characterization of platelet-derived growth factor beta-receptor expressing cells in the vasculature of human rheumatoid synovium.

Authors:  C Reuterdahl; A Tingström; L Terracio; K Funa; C H Heldin; K Rubin
Journal:  Lab Invest       Date:  1991-03       Impact factor: 5.662

8.  Control of fibroblast growth factor receptor kinase signal transduction by heterodimerization of combinatorial splice variants.

Authors:  E Shi; M Kan; J Xu; F Wang; J Hou; W L McKeehan
Journal:  Mol Cell Biol       Date:  1993-07       Impact factor: 4.272

9.  Control of BEK and K-SAM splice sites in alternative splicing of the fibroblast growth factor receptor 2 pre-mRNA.

Authors:  E Gilbert; F Del Gatto; P Champion-Arnaud; M C Gesnel; R Breathnach
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

10.  Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis.

Authors:  A E Koch; L A Harlow; G K Haines; E P Amento; E N Unemori; W L Wong; R M Pope; N Ferrara
Journal:  J Immunol       Date:  1994-04-15       Impact factor: 5.422

View more
  1 in total

Review 1.  Novel risk factors for cardiovascular disease in rheumatoid arthritis.

Authors:  Jenny Amaya-Amaya; Juan Camilo Sarmiento-Monroy; Ruben-Dario Mantilla; Ricardo Pineda-Tamayo; Adriana Rojas-Villarraga; Juan-Manuel Anaya
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.